Nuvilex, Inc. and Diabetes Research Institute Have Similar Approach to Islet Cell Transplantation NEW YORK, NY--(Marketwired - Apr 18, 2013) -  Nuvilex, Inc. (OTCQB: NVLX) has "Cell-in-a-Box," the Diabetes Research Institute has BioHub. One is cell encapsulation technology, and the...

Human Clinical Trials Using Medical Marijuana Could Be Close in the U.S. NEW YORK, NY--(Marketwired - Apr 16, 2013) - With more and more acceptance of medical marijuana here in the U.S., companies like Nuvilex, Inc. (OTCQB: NVLX), and research centers like the...

Nuvilex, Inc. Can Benefit From Passage of This Week's Medical Marijuana Bill NEW YORK, NY--(Marketwired - Apr 10, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its subsidiary Medical Marijuana Sciences, Inc. received some good news this week as Maryland lawmakers passed a bill...

Nuvilex, Inc. Expects its Technology Can Start to Change Life for Diabetics NEW YORK, NY--(Marketwired - Apr 8, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) started its diabetes studies, it was likely well known then that while its late-stage pancreatic cancer trials are front...

Timing Is Right for Big Pharma to Add Nuvilex, Inc. Technology to Its Pipeline NEW YORK, NY--(Marketwire - Mar 21, 2013) -  Nuvilex, Inc. (OTCQB: NVLX) has close to $30-million invested in its "Cell-in-a-Box" technology, and as the company gets closer to the start of its...